|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.18 EUR | +3.30% |
|
+1.92% | -19.73% |
| 05-12 | Stratec SE, Q1 2026 Earnings Call, May 11, 2026 | |
| 05-12 | STRATEC BIOMEDICAL SYSTEMS AG : Gets a Neutral rating from Deutsche Bank | ZD |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 18.5 | 19.96 | 22.9 |
| Spread/Res. | -2.59% | -9.72% | -21.31% |
| Spread/Supp. | +9.08% | +9.08% | +7.52% |
| Support | 16.52 | 16.52 | 16.76 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SBS Stock
- Charts Stratec SE
Select your edition
All financial news and data tailored to specific country editions
